Perspective Therapeutics (CATX) Operating Margin Growth (1y) (2011 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -430.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 128.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -361.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 102.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 241.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 851.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -313.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 535.00
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 -20,115.00
Jun 30, 2023 -56,619.00
Mar 31, 2023 -48,610.00
Sep 30, 2022 -15,639.00
Jun 30, 2022 -13,374.00
Mar 31, 2022 -1,782.00
Dec 31, 2021 -2,105.00
Sep 30, 2021 -5,874.00
Jun 30, 2021 10,184.00
Mar 31, 2021 -1,043.00
Dec 31, 2020 393.00
Sep 30, 2020 616.00
Jun 30, 2020 729.00
Mar 31, 2020 4,142.00
Dec 31, 2019 3,412.00
Sep 30, 2019 6,107.00
Jun 30, 2019 8,839.00
Mar 31, 2019 2,468.00
Dec 31, 2018 2,052.00
Sep 30, 2018 3,098.00
Jun 30, 2018 -1,179.00
Mar 31, 2018 2,322.00
Dec 31, 2017 4,830.00
Sep 30, 2017 1,754.00
Jun 30, 2017 -2,409.00
Mar 31, 2017 242.00
Dec 31, 2016 -2,528.00
Sep 30, 2016 -5,918.00
Jun 30, 2016 -2,958.00
Mar 31, 2016 -2,002.00
Dec 31, 2015 -2,284.00
Sep 30, 2015 2,490.00
Jun 30, 2015 5,667.00
Mar 31, 2015 -356.00
Dec 31, 2014 47.00
Sep 30, 2014 616.00
Jun 30, 2014 -5,686.00
Mar 31, 2014 -2,134.00
Dec 31, 2013 1,649.00
Sep 30, 2013 -1,128.00
Jun 30, 2013 -1,048.00
Mar 31, 2013 -794.00
Dec 31, 2012 -4,825.00
Sep 30, 2012 -1,546.00
Jun 30, 2012 -1,071.00
Mar 31, 2012 -875.00
Dec 31, 2011 -1,349.00
Sep 30, 2011 -2,540.00